Close Menu

Selventa

Selventa Raises $5M

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Life science data analysis firm Selventa has raised $5 million in an equity round, it disclosed in a document filed with the US Securities and Exchange Commission this week.

Selventa said this week that it has partnered with Linguamatics to add natural language processing-based text-mining capability to its knowledge-extraction and discovery platform.

People in the News

Premium

Selventa CEO David de Graaf has been selected to serve on the scientific advisory board of the Massachusetts Institute of Technology's Center for Cancer Systems Biology.

People in the News

Premium

The Swiss Institute of Bioinformatics has tapped Selventa's CEO David de Graaf and Alexey Nesvizhskii, an assistant professor at the University of Michigan, Ann Arbor, to serve on its scientific advisory board.

Movers & Shakers

Premium

The Swiss Institute of Bioinformatics has appointed David de Graaf and Alexey Nesvizhskii to serve on its scientific advisory board.

People in the News

Premium

Luis Serrano, James Collins, Mathukumalli Vidyasagar, Joel Saltz

Pfizer and Selventa plan to create a publicly available version of Selventa's Biological Expression Language and associated BEL Framework that will enable groups to capture, store, combine, and use scientific knowledge to inform decision-making for drug targets.

People in the News

Premium

John Tagliamonte

Pages

According to New Scientist, GEDmatch changed its terms and conditions over the weekend to opt its users out of law enforcement searches.

The Atlantic looks into time spent pursuing gene leads generated through candidate gene studies.

A twin study uncovers evidence that genes may influence whether someone gets a dog, Martha Stewart reports.

In PNAS this week: Cdx2 cells can help regenerate heart tissue in mice following a heart attack, PIWI-interacting small RNA levels in human cancer, and more.